Searching for biological markers of molecular targeting treatment of liver cancer
Arao, T.; Kudo, M.; Nishio, K.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(10): 1879-1882
2010
ISSN/ISBN: 0385-0684 PMID: 21069943 Document Number: 645256
Document emailed within 1 workday
Related Documents
Stepanova, E.V.; Zagrekova, E.I.; Ermilova, V.D.; Turbin, A.D.; Petrovichev, N.N.; Vysotskaia, I.V.; Dbar, Z.N.; Pashchenko, N.V.; Baryshnikov, A.I.; Lichinitser, M.R. 2003: Molecular-biological markers as prognostic factors in breast cancer of I-IIA stage Arkhiv Patologii 65(3): 14-18Demetter, P.; Maréchal, R.; Verset, L.; Salmon, I.; Bachet, J.-B.; Van Laethem, J.L. 2012: Molecular changes in pancreatic cancer: implications for molecular targeting therapy Acta Gastro-Enterologica Belgica 75(2): 210-214
Domagała, P.; Kowalik, A. 2014: Examination of molecular markers used n the treatment of colon cancer Polish Journal of Pathology: Official Journal of the Polish Society of Pathologists 65(4 Suppl 1: S59-S77
Worman, H.J. 1997: Molecular biological methods in diagnosis and treatment of liver diseases Clinical Chemistry 43(8 Pt 2): 1476-1486
Tahara, M. 2012: II. Molecular targeting therapy for head and neck cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(7): 1055-1060
Naka, N. 2012: II. Possibility of molecular targeting therapy for musculoskeletal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(3): 373-377
Fujii, M. 2013: IV. Molecular targeting therapy for head and neck cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(7): 867-870
Koike, S. 1991: Targeting cancer chemotherapy for metastatic liver cancer--effects of DSM on hepatic hemodynamics and on clinical outcome Nihon Geka Gakkai Zasshi 92(2): 187-194
Silvestrini, R.; Costa, A.; Faranda, A. 1996: Biological prospectives to define prognosis and treatment strategies in liver metastases from colorectal cancer Annali Italiani di Chirurgia 67(6): 733-737
Okamoto, I. 2008: Molecular targeting therapy for treatment of non-small-cell lung carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(8): 1303-1309
Engelstein, D. 2017: Molecular Markers for Prostate Cancer Harefuah 156(5): 318-321
Miyachi, H.; Asai, S. 2003: Genetic tests for molecular markers of cancer Rinsho Byori. Japanese Journal of Clinical Pathology 51(12): 1195-1202
Numa, F.; Umayahara, K.; Suehiro, Y.; Suminami, Y.; Oga, A.; Sasaki, K.; Kato, H. 2001: New molecular tumor markers for endometrial cancer Human Cell 14(4): 272-274
Fradet, Y. 1990: Biological markers of prognosis in invasive bladder cancer Seminars in Oncology 17(5): 533-543
Nemtsova, M.V.; Bykov, I.I.; Tchekinova, N.V.; Zaletaev, D.V.; Glikhov, A.I.; Khorobrykh, T.V. 2013: The systems of molecular genetic markers under cancer of stomach Klinicheskaia Laboratornaia Diagnostika 11: 12-15
Le Maire, V.; Sales, J.P.; Wind, P.; Dumas, F.; Landi, B.; Fayemendy, L.; Cugnenc, P.H.; Gayral, F.; Lacour, B.; Loric, S. 1998: Evaluation and interest in new molecular markers in colon cancer Annales Pharmaceutiques Francaises 56(1): 9-17
Tabe, Y. 2009: Molecular diagnosis of and molecular targeting therapy for leukemia Rinsho Byori. Japanese Journal of Clinical Pathology 57(2): 137-145
Sekido, Y. 2000: Molecular biological approaches to lung cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 58(5): 1036-1040
de Oliveira e Silva, A.; Roldan-Molina, F.; dos Santos, T.E.; Santo, G.C.; Miranda, M.P.; Genzini, T.; Neves, L.B.; D'Albuquerque, L.A. 1990: Diagnosis of hepatocellular carcinoma performed by searching for serologic tumor markers Arquivos de Gastroenterologia 27(2): 83-94
Khakimov, G.A.; Shayusupov, N.R.; Miryusupova, G.F. 2015: Molecular-biological subtypes of breast cancer in the Republic of Uzbekistan Voprosy Onkologii 61(6): 1018-1020